These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36647666)

  • 1. [Clinical Analysis of Voriconazole Concentrations in Cerebrospinal Fluid and Blood in Patients with Ryptococcal Meningitis].
    Xiao GR; Liu ZZ; Tang GM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):192-197. PubMed ID: 36647666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders.
    Mafuru M; Wu S; He S; Lu X; Huang J; Jiang H
    J Clin Pharmacol; 2019 Oct; 59(10):1340-1350. PubMed ID: 30997931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.
    Encalada Ventura MA; van Wanrooy MJ; Span LF; Rodgers MG; van den Heuvel ER; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
    Antimicrob Agents Chemother; 2016 May; 60(5):2727-31. PubMed ID: 26883707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
    Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
    Zeng G; Wang L; Shi L; Li H; Zhu M; Luo J; Zhang Z
    Eur J Clin Pharmacol; 2020 Apr; 76(4):515-523. PubMed ID: 31932875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole.
    Vreugdenhil B; van der Velden WJFM; Feuth T; Kox M; Pickkers P; van de Veerdonk FL; Blijlevens NMA; Brüggemann RJM
    Br J Clin Pharmacol; 2018 Sep; 84(9):1980-1988. PubMed ID: 29744898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Voriconazole Trough Plasma Concentration with Efficacy and Incidence of Hepatotoxicity in Iranian Patients with Hematological Malignancies.
    Taghvaye-Masoumi H; Hadjibabaie M; Ghadimi M; Zarif-Yeganeh M; Vaezi M; Ghavamzadeh A
    Iran J Pharm Res; 2021; 20(1):62-71. PubMed ID: 34400941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age.
    Gastine SE; Rauwolf KK; Pieper S; Hempel G; Lehrnbecher T; Tragiannidis A; Groll AH
    Mycoses; 2023 Nov; 66(11):969-976. PubMed ID: 37553971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients.
    Cheng L; You X; Wang X; Yu M; Jia C
    Drug Des Devel Ther; 2024; 18():3617-3628. PubMed ID: 39156484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of procalcitonin with voriconazole concentrations: a retrospective cohort study.
    Zhou JX; Xiong CL; Chang ZS; Yin YC; Su KP; Zhang JH; Wu JC; Sun B
    BMC Infect Dis; 2024 Sep; 24(1):952. PubMed ID: 39256640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole: a novel treatment option for cryptococcal meningitis.
    Yao Y; Zhang JT; Yan B; Gao T; Xing XW; Tian CL; Huang XS; Yu SY
    Infect Dis (Lond); 2015; 47(10):694-700. PubMed ID: 26100526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center.
    Lindsay J; Krantz EM; Morris J; Sweet A; Tverdek F; Joshi A; Yeh R; Hill JA; Greenwood M; Chen SC; Kong DCM; Slavin M; Pergam SA; Liu C
    Transplant Cell Ther; 2022 Aug; 28(8):511.e1-511.e10. PubMed ID: 35623614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of plasma trough concentration of voriconazole in adult patients using machine learning.
    Cheng L; Zhao Y; Liang Z; You X; Jia C; Liu X; Wang Q; Sun F
    Eur J Pharm Sci; 2023 Sep; 188():106506. PubMed ID: 37356464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
    Gazzoni AF; Capilla J; Mayayo E; Guarro J
    Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
    Kwizera R; Akampurira A; Kandole TK; Nielsen K; Kambugu A; Meya DB; Boulware DR; Rhein J;
    BMC Microbiol; 2017 Aug; 17(1):182. PubMed ID: 28830348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections.
    Lamoureux F; Duflot T; Woillard JB; Metsu D; Pereira T; Compagnon P; Morisse-Pradier H; El Kholy M; Thiberville L; Stojanova J; Thuillez C
    Int J Antimicrob Agents; 2016 Feb; 47(2):124-31. PubMed ID: 26775563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.